Dementia and Neurocognitive Disorders (대한치매학회지)

Korean Dementia Association (대한치매학회)
권호 표지

Insulin Resistance and Cognitive Impairment in Non-Diabetic Patients

  • Park, Hyung-Jong (Department of Neurology, Wonkwang University School of Medicine, Institute of Wonkwang Medical Science) ;
  • Park, Do-Sim (Department of Laboratory Medicine, Wonkwang University School of Medicine, Institute of Wonkwang Medical Science) ;
  • Park, Hyun-Young (Department of Neurology, Wonkwang University School of Medicine, Institute of Wonkwang Medical Science) ;
  • Chang, Hyuk (Department of Neurology, Wonkwang University School of Medicine, Institute of Wonkwang Medical Science) ;
  • Kim, Yo-Sik (Department of Neurology, Wonkwang University School of Medicine, Institute of Wonkwang Medical Science)
  • Published : 2010.12.30
⟨ Previous Next ⟩

Abstract

Background: Type 2 diabetes mellitus (DM2) is associated with cognitive impairment. Peripheral insulin resistance is known to be the major contributor to the progression of hyperglycemia and DM. However, the relationship between insulin resistance (IR) and the risk of cognitive decline in non-diabetic patients is not clear so far. Methods: We analyzed 18 Alzheimer disease (AD) patients, 19 mild cognitive impairment (MCI) patients, and 24 cognitively healthy controls without diabetes. We examined their demographic characteristics, current and past illness and Mini-Mental State Examination (MMSE). We also examined insulin resistance index (Homeostasis Model Assessment of Insulin Resistance, HOMA-IR) as an indicator of IR and a factor associated with cognitive decline. Results: Levels of HOMA-IR were significantly different among the 3 groups (p<0.05) and HOMA-IR levels detected in the AD group were higher than those in the MCI and control groups. They were negatively correlated with the MMSE (p<0.01) and significantly connected with the cognitive decline subjects (r=-0.351, p<0.01). Multiple regression analysis revealed that the level of HOMA-IR was independently associated with cognitive decline (p<0.05). Conclusions: HOMA-IR levels were related to cognitive decline and these results suggest that HOMA-IR may be an important risk factor of dementia.

Keywords

References

  1. Geroldi C, Frisoni GB, Paolisso G, Bandinelli S, Lamponi M, Abbatecola AM, et al. Insulin resistance in cognitive impairment: the InCHIANTI study. Arch Neurol 2005; 62: 1067-72. https://doi.org/10.1001/archneur.62.7.1067
  2. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, Brooks J, et al. Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging 2009 e-pub.
  3. Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurol 2010; 75: 764-70. https://doi.org/10.1212/WNL.0b013e3181eee25f
  4. Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB. Insulin resistance and Alzheimer's disease: molecular links & clinical implications. Curr Alzheimer Res 2008; 5: 438-47. https://doi.org/10.2174/156720508785908919
  5. Abbatecola AM, Paolisso G, Lamponi M, Bandinelli S, Lauretani F, Launer L, et al. Insulin resistance and executive dysfunction in older persons. J Am Geriatr Soc 2004; 52: 1713-8. https://doi.org/10.1111/j.1532-5415.2004.52466.x
  6. Luchsinger JA, Tang MX, Shea S, Mayeus R. Hyperinsulinemia and risk of Alzheimer disease. Neurol 2004; 63: 1187-92. https://doi.org/10.1212/01.WNL.0000140292.04932.87
  7. van den Berg E, Dekker JM, Nijpels G, Kessels RP, Kappelle LJ, de Haan EH, et al. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the Hoorn study. Dement Geriatr Cogn Disord 2008; 26: 261-9. https://doi.org/10.1159/000160959
  8. Bourdel-Marchasson I, Lapre E, Laksir H, Puget E. Insulin resistance, diabetes and cognitive function: consequences for preventative strategies. Diabetes Metab 2010; 36: 173-81. https://doi.org/10.1016/j.diabet.2010.03.001
  9. Perterson RC. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine 2004; 256: 183-94. https://doi.org/10.1111/j.1365-2796.2004.01388.x
  10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurol 1984; 34: 939-44. https://doi.org/10.1212/WNL.34.7.939
  11. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007; 6: 734-46. https://doi.org/10.1016/S1474-4422(07)70178-3
  12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, RC. Homeostasis model assessment: insulin resistance and $\beta$-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9. https://doi.org/10.1007/BF00280883
  13. Young SE, Mainous AG III, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 2006; 29: 2688-93. https://doi.org/10.2337/dc06-0915
  14. Hallschmid M, Schultes B. Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders? Diabetologia 2009; 52: 2264-9. https://doi.org/10.1007/s00125-009-1501-x
  15. Umegaki H. Pathophysiology of cognitive dysfunction in older people with type 2 diabetes: vascular changes or neurodegeneration? Age Ageing 2010; 39: 8-10. https://doi.org/10.1093/ageing/afp211
  16. Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, et al. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes 2010; 59: 1601-7. https://doi.org/10.2337/db09-0568
  17. Bruehl H, Sweat V, Hassenstab J, Polyakov V, Convit A. Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance. J Clin Exp Neuropsychol 2010; 32: 487-93. https://doi.org/10.1080/13803390903224928